David Carroll - Dec 12, 2021 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP, CFO and Treasurer
Signature
/s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll
Stock symbol
ISEE
Transactions as of
Dec 12, 2021
Transactions value $
-$86,051
Form type
4
Date filed
12/14/2021, 05:08 PM
Previous filing
Dec 13, 2021
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +12.5K +13.78% 103K Dec 12, 2021 Direct F1
transaction ISEE Common Stock Sale -$86.1K -5.84K -5.65% $14.74 97.4K Dec 13, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -12.5K -50% $0.00 12.5K Dec 12, 2021 Common Stock 12.5K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 12, 2021.
F3 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $14.50 to $14.99 on December 13, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F4 On December 12, 2018, the Reporting Person was granted an award of 50,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.